Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy
INTRODUCTION: Voriconazole plasma concentrations have been correlated with oral dosing in healthy subjects, but have been poorly characterized in ill patients with hematological malignancies receiving intensive chemotherapy.
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Canadian Journal of Infectious Diseases and Medical Microbiology |
Online Access: | http://dx.doi.org/10.1155/2014/214813 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832553752746262528 |
---|---|
author | Lalit Saini Jack T Seki Deepali Kumar Eshetu G Atenafu David EC Cole Betty YL Wong Andrea Božović Joseph M Brandwein |
author_facet | Lalit Saini Jack T Seki Deepali Kumar Eshetu G Atenafu David EC Cole Betty YL Wong Andrea Božović Joseph M Brandwein |
author_sort | Lalit Saini |
collection | DOAJ |
description | INTRODUCTION: Voriconazole plasma concentrations have been correlated with oral dosing in healthy subjects, but have been poorly characterized in ill patients with hematological malignancies receiving intensive chemotherapy. |
format | Article |
id | doaj-art-6c379212e1fc49e4aa8c3acb7be885d9 |
institution | Kabale University |
issn | 1712-9532 |
language | English |
publishDate | 2014-01-01 |
publisher | Wiley |
record_format | Article |
series | Canadian Journal of Infectious Diseases and Medical Microbiology |
spelling | doaj-art-6c379212e1fc49e4aa8c3acb7be885d92025-02-03T05:53:16ZengWileyCanadian Journal of Infectious Diseases and Medical Microbiology1712-95322014-01-0125527127610.1155/2014/214813Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole TherapyLalit Saini0Jack T Seki1Deepali Kumar2Eshetu G Atenafu3David EC Cole4Betty YL Wong5Andrea Božović6Joseph M Brandwein7Division of Hematology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaDepartment of Pharmacy, Princess Margaret Cancer Centre, CanadaTransplant Infectious Diseases, Alberta Transplant Institute, CanadaBiostatistics Department, Princess Margaret Cancer Centre, CanadaDepartment of Laboratory Medicine and Pathophysiology and Department of Clinical Pathology, University of Toronto, CanadaDepartment of Clinical Pathology, Sunnybrook Health Sciences Centre, CanadaLaboratory Medicine Program, Toronto General Hospital, University Health Network, CanadaDivision of Hematology, Department of Medicine, University of Alberta, Edmonton, Alberta, CanadaINTRODUCTION: Voriconazole plasma concentrations have been correlated with oral dosing in healthy subjects, but have been poorly characterized in ill patients with hematological malignancies receiving intensive chemotherapy.http://dx.doi.org/10.1155/2014/214813 |
spellingShingle | Lalit Saini Jack T Seki Deepali Kumar Eshetu G Atenafu David EC Cole Betty YL Wong Andrea Božović Joseph M Brandwein Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy Canadian Journal of Infectious Diseases and Medical Microbiology |
title | Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy |
title_full | Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy |
title_fullStr | Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy |
title_full_unstemmed | Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy |
title_short | Serum Voriconazole Level Variability in Patients with Hematological Malignancies Receiving Voriconazole Therapy |
title_sort | serum voriconazole level variability in patients with hematological malignancies receiving voriconazole therapy |
url | http://dx.doi.org/10.1155/2014/214813 |
work_keys_str_mv | AT lalitsaini serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy AT jacktseki serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy AT deepalikumar serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy AT eshetugatenafu serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy AT davideccole serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy AT bettyylwong serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy AT andreabozovic serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy AT josephmbrandwein serumvoriconazolelevelvariabilityinpatientswithhematologicalmalignanciesreceivingvoriconazoletherapy |